AIM ImmunoTech Inc.

Biotechnology company · Ocala, Florida, United States · NYSE: AIM

AIM ImmunoTech Inc. is a biotechnology company headquartered in Ocala, Florida, United States. Its shares trade on NYSE under the ticker AIM. It has reported private securities offerings to the US SEC, most recently $3.3 million sold in a notice filed in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

AIM ImmunoTech at a glance

Typebiotechnology company

HeadquartersOcala, Florida, United States

Stock listingNYSE: AIM

SEC industryBiological Products, (No Diagnostic Substances)

SEC CIK946644

What does AIM ImmunoTech do?

Private fundraising reported to the SEC

5 Form D notices; the most recent reported $3.3 million sold (2024).

Frequently asked questions about AIM ImmunoTech

Where is AIM ImmunoTech headquartered?

AIM ImmunoTech Inc. is headquartered in Ocala, Florida, United States.

What does AIM ImmunoTech do?

AIM ImmunoTech Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is AIM ImmunoTech a public company?

Yes. AIM ImmunoTech Inc. trades on NYSE under the ticker AIM.

Similar companies

Recursion PharmaceuticalsSalt Lake City, Utah, United States
Vericel CorpBurlington, Massachusetts, United States
SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Adaptive Biotechnologies CorpSeattle, Washington, United States
Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
Cognition Therapeutics IncPurchase, New York, United States
Agenus IncLexington, Massachusetts, United States
Vaxcyte, Inc.San Carlos, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.